k8¿­·¢(Öйú)

ÕâÊÇÃèÊöÐÅÏ¢

ÍâÃÚÌåÑо¿

È«²¿·ÖÀà
ÁôÑÔ×Éѯ
Óë×îÐÂÏûÏ¢±£´æͬ²½
1/1
ä¯ÀÀÁ¿:
1000

ÍâÃÚÌåȫת¼×é²âÐò·þÎñ

k8¿­·¢(Öйú)ÍƳöµÄÍâÃÚÌåȫת¼×é²âÐò·þÎñ£¬²»½ö¿ÉÒÔ½øÐÐÉîÈëµÄ»ùÒò¹¦ÄÜ×¢ÊÍ£¬¶øÇÒ»¹Äܹ»·ÖÎöµ½ÍâÃÚÌå¿ÉÄÜÀ´Ô´µÄϸ°ûÀàÐͼ°Õ¼±È£¨ÍâÃÚÌåËÝÔ´£©£¬¶ÔÓÚÉîÈëÁ˽ⲻͬ·¢Óý½×¶Î»ò¼²²¡×´Ì¬±³ºóµÄÍâÃÚÌåµ÷¿Ø»úÖƾßÓÐÊ®·ÖÖØÒªµÄÒâÒå¡£
ÁãÊÛ¼Û
0.0
Ôª
Êг¡¼Û
0.0
Ôª
ä¯ÀÀÁ¿:
1000
²úÆ·±àºÅ
ÊýÁ¿
-
+
¿â´æ:
0
Á¢¼´×Éѯ
1
²úÆ·ÃèÊö

       ÍâÃÚÌåÖÐЯ´øÓÐÀ´×Ôĸ±¾Ï¸°ûµÄ¶àÖÖµ°°×ÖÊ¡¢Ö¬Àà¡¢RNAµÈÖØÒªÐÅÏ¢¡£¶ÔÍâÃÚÌåÖеij¤Á´RNAs½øÐÐȫת¼×é²âÐò·ÖÎö£¬Ò»´Î²âÐòʵÑ飬¼´¿ÉÒÔ»ñµÃÉÏÍòÌõ³¤Á´RNAsµÄ¼ì²âÊý¾Ý£¬È«Ã渲¸Ç mRNA¡¢lncRNAºÍ circRNAµÈ³¤Á´RNAs¡£ÍâÃÚÌåȫת¼×é²âÐòÊý¾ÝÁ¿´ó¡¢ÐÅϢȫÃ棬ÊÇ·¢ÏÖÌØÒìÐÔ¼²²¡Õï¶Ï±êÖ¾Îï¡¢½øÐжà×éѧ·ÖÎöµÄÖØÒªÊֶΡ£Í¬Ê±£¬ÓÉÓÚÍâÃÚÌåЯ´øµÄ³¤Á´RNAsÖÐÓг¬¹ý70%ΪmRNA£¬ÍâÃÚÌåȫת¼×é²âÐòµÄ½á¹û²»½ö¿ÉÒÔ½øÐÐÉîÈëµÄ»ùÒò¹¦ÄÜ×¢ÊÍ£¬¶øÇÒ»¹Äܹ»·ÖÎöµ½ÍâÃÚÌå¿ÉÄÜÀ´Ô´µÄϸ°ûÀàÐͼ°Õ¼±È£¨¼´ÍâÃÚÌåËÝÔ´£©¡£

 
 
 

 

|   k8¿­·¢(Öйú)ȫת¼×é²âÐò·þÎñ

       k8¿­·¢(Öйú)ÍâÃÚÌåȫת¼×é²âÐò·þÎñÌåϵ£¬³ä·Ö½áºÏÁËרÀû΢Á¿ºËËὨ¿â¼¼Êõ¡¢NGS¼¼ÊõºÍȫеÄÉúÎïÐÅÏ¢ÐòÁбȶÔËã·¨£¬¿É¶ÔѪ½¬ÖÐÍâÃÚÌåµÄmRNA¡¢lncRNAºÍcircRNA µÈRNAs½øÐгä·Ö²¶»ñºÍ²âÐò£¬¿ÉÒÔʵÏÖ´Ó1mLѪ½¬·ÖÀëµÄÍâÃÚÌåÖУ¬Îȶ¨¼ì³ö³¬¹ý1ÍòÌõ³¤Á´RNAs¡£

|   ·ÖÎöÄÚÈÝ

|   ¾­µä°¸Àý£ºÑª½¬ÍâÃÚÌåȫת¼×éɸѡÒÈÏÙ°©±êÖ¾Îï·¢ÏÖ

       2020Ä꣬¸´µ©´óѧ¸½ÊôÖ×ÁöÒ½ÔºÑо¿ÍŶӴÓ1mLѪ½¬ÖзÖÀëÍâÃÚÌ壬ÀûÓÃרÀû½¨¿â¼¼Êõ½øÐÐȫת¼×é²âÐò£¬³É¹¦É¸Ñ¡µ½ÁË8ÖÖ³¤Á´RNA£¬ÆäÐγɵÄÒÈÏÙ°©Õï¶Ï±êÖ¾Îï×éºÏ£¬±È´«Í³µÄCA19-9¸ü¼ÓÁéÃôºÍÌØÒì¡£

       ÍâÃÚÌåȫת¼×é²âÐò½á¹ûÏÔʾ£ºÈë×éÈËȺѪ½¬ÍâÃÚÌåÖеÄmRNAÆձ鸻¼¯¶È×î¸ß£¬Æä´ÎÊÇLncRNA¡£Ëæ»úÉ­ÁÖµÈÊý¾Ý·ÖÎö·¢ÏÖ8ÖÖ³¤Á´RNAÔÚPDAC»¼ÕßÖÐÆÕ±é¸ßÓÚCPºÍHC×飬¿É×÷ΪDZÔÚÕï¶Ï±êÖ¾Îï¡£ÓÉ8ÖÖ³¤Á´RNA×é³ÉµÄ±êÖ¾Îï×éºÏd-signature¶ÔÓÚ¢ñºÍ¢òÆÚÒÈÏÙµ¼¹ÜÏÙ°©µÄÕï¶ÏЧÄÜAUC ´ïµ½0.949£¬ Ô¶¸ßÓÚ¾­µä±êÖ¾ÎïCA19 -9 ¡£ÁªºÏd-signatureºÍCA19-9Õï¶Ïʱ£¬Õï¶ÏЧÄܽøÒ»²½Ìá¸ßµ½AUC=0.964¡£

 

|   »ªÓ¯ÓÅÊÆ

1. һվʽ·þÎñÌåϵ£º

¿Í»§Ö»ÐèÌṩѪ½¬Ñù±¾£¬k8¿­·¢(Öйú)ΪÄúÍê³É´ÓÑùÆ·×¼±¸£¬ÎÄ¿âÖƱ¸£¬ÉÏ»ú²âÐòµ½Êý¾Ý·ÖÎöÕûÌ×·þÎñÁ÷³Ì¡£

2.רÀû½¨¿â¼¼Êõ£º

k8¿­·¢(Öйú)²ÉÓõÄרÀû΢Á¿ºËËὨ¿â¼¼Êõ£¬¿É¶Ô½ö1mLѪ½¬ÖÐÌáÈ¡µÄÍâÃÚÌåRNA½øÐн¨¿âºÍ²âÐò·ÖÎö¡£

3.רҵÉúÎïÐÅÏ¢·ÖÎö£º

k8¿­·¢(Öйú)¾ßÓÐÇ¿´óµÄÉúÎïÐÅϢѧÍŶÓ£¬Äܹ»Âú×ã¿Í»§µÄ¸÷ÀàÉîÈëÊý¾Ý·ÖÎöÒªÇó£¬Ïà¹Ø·ÖÎöʾÀýÈçÏ£º

 

 Ïà¹ØÎÄÏ×

[1]. Xihao Du, Qingli Zhang, Yixuan Jiang, et al. Dynamic molecular choreography induced by traffic exposure: A randomized, crossover trial using multi-omics profiling. J Hazard Mater. 2022 Feb 15;424(Pt A):127359. IF=10.588

[2]Jin Ji, Rui Chen, Lin Zhao, et al. Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer. Mol Cancer. 2021 Mar 30;20(1):58. IF=27.401

[3]. Chu-Wen Chen, Min Fu, Zhi-Hao Du, et al. Long Noncoding RNA MRPL23-AS1 Promoteoid Cystic Carcinoma Lung Metastasis. Cancer Res. 2020 Jun 1;80(11):2273-2285. IF=12.479

[4]Shulin Yu, Yuchen Li, Zhuan Liao, et al. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma]. Gut, 2019, 69(3):gutjnl-2019-318860. IF=23.059

[5]Yuchen Li, Jingjing Zhao, Shulin Yu, et al. Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis. Clin Chem. 2019 Jun;65(6):798-808. IF=8.327

¹Ø¼ü´Ê:
ȫת¼×é²âÐò
k8¿­·¢(Öйú)
ÍâÃÚÌåÑо¿
mRNA
δÕÒµ½ÏàÓ¦²ÎÊý×飬ÇëÓÚºǫ́ÊôÐÔÄ£°åÖÐÌí¼Ó
k8¿­·¢(Öйú)

µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã

µç»°£º400-869-2936£¬021-33968791

ÓÊÏ䣺support@wayenbiotech.com

´«Õ棺021-33938792

QQ£º2120485725

Õ½ÂÔºÏ×÷

Õ½ÂÔºÏ×÷

·¢²¼Ê±¼ä£º2021-08-11 17:21:10

|    Full Moon    |    RayBiotech    |    CDI    |    IZON    |    Bio-Rad    |    R&D Systems    |    IsoPlexis    |    ÄÏÄ£ÉúÎï    |    Å·Ò×ÉúÎï    |    ÆäÃ÷ÐÅÏ¢    |    ÃÀ¼ªÉúÎï    |    ÂóÌØ»æÆ×    | 

 

Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿­·¢(Öйú)Ô­´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿­·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£

רÀû´úÂë

·¢²¼Ê±¼ä£º2023-06-09 17:38:30
Copyright @ 2021 ÉϺ£k8¿­·¢(Öйú)Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾ °æȨËùÓÐ
Record »¦ICP±¸2022031428ºÅ-1
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ÉϺ£
ËÑË÷
ËÑË÷
¹Ø±Õ
¿Í»§ÁôÑÔ
ÑéÖ¤Âë